Oral acetazolamide for intraocular pressure lowering: balancing efficacy and safety in ophthalmic practice

References

• Becker B. Decrease in Intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox*. Am J Ophthalmol. 1954;37(1):13–15.
   PubMed Web of Science ®Google Scholar
• Becker B. The effects of the carbonic anhydrase inhibitor, acetazoleamide, on the composition of the aqueous humor*. Am J Ophthalmol. 1955;40(5):129–136.
   PubMed Web of Science ®Google Scholar
• Hewett-Emmett D, Hopkins PJ, Tashian RE, et al. Origins and molecular evolution of the carbonic anhydrase isozymes. Ann N Y Acad Sci. 1984;429:338–358.
   PubMedGoogle Scholar
• Lütjen-Drecoll E, Lönnerholm G, Eichhorn M. Carbonic anhydrase distribution in the human and monkey eye by light and electron microscopy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1983;220(6):285–291.
   PubMed Web of Science ®Google Scholar
• Wistrand PJ. Human renal cytoplasmic carbonic anhydrase. Tissue levels and kinetic properties under near physiological conditions. Acta Physiol Scand. 1980;109(3):239–248.
   PubMedGoogle Scholar
• Wisfrand PJ, Schenholm M, Lonnerholm G Carbonic Anhydrase Isoenzymes CA I and CA II in the Human Eye.: 10.
   Google Scholar
• Wistrand PJ, Garg LC. Evidence of a high-activity C type of carbonic anhydrase in human ciliary processes. Invest Ophthalmol Vis Sci. 1979;18(8):802–806.
   PubMed Web of Science ®Google Scholar
• Kumpulainen T. Immunohistochemical demonstration of carbonic anhydrase isoenzyme C in the epithelium of the human ciliary processes. Histochemistry. 1983;77(2):281–284.
   PubMedGoogle Scholar
• Wistrand PJ. The importance of carbonic anhydrase B and C for the unloading of CO2 by the human erythrocyte. Acta Physiol Scand. 1981;113(4):417–426.
   PubMedGoogle Scholar
• Bloom JN, Levene RZ, Thomas G, et al. Fluorophotometry and the rate of aqueous flow in man. I. Instrumentation and normal values. Arch Ophthalmol Chic Ill. 1976;94(3):435–443.
   PubMedGoogle Scholar
• Linner E, Friedenwald JS. The appearance time of fluorescein as an index of aqueous flow. Am J Ophthalmol. 1957;44(2):225–229.
   PubMed Web of Science ®Google Scholar
• Holm O, Wiebert O. The effect of systemically given acetazolamide (Diamox) upon the formation of aqueous humour in the human eye, measured with a new photogrammetric method. Acta Ophthalmol (Copenh). 1968;46(6):1243–1250.
   PubMed Web of Science ®Google Scholar
• Constant MA, Falch J. PHOSPHATE AND PROTEIN CONCENTRATIONS OF INTRAOCULAR FLUIDS. I. EFFECT OF CARBONIC ANHYDRASE INHIBITION IN YOUNG AND OLD RABBITS. Invest Ophthalmol. 1963;2:332–343.
   PubMedGoogle Scholar
• Becker B. The effects of acetazoleamide on ascorbic-acid turnover; an application of the theory of aqueous humor dynamics. Am J Ophthalmol. 1956;41(3):522–529.
   PubMed Web of Science ®Google Scholar
• Kinsey VE, Reddy DV, Skrentny BA. Intraocular transport of C14-labeled urea and the influence of Diamox on its rate of accumulation in aqueous humors. Am J Ophthalmol. 1960;50:1130–1141.
   PubMed Web of Science ®Google Scholar
• Becker B. The measurement of rate of aqueous flow with iodide. Invest Ophthalmol. 1962;1:52–58.
   PubMedGoogle Scholar
• Macri FJ, Dixon RL, Rall DP. Aqueous humor turnover rates in the cat. I. Effect of acetazolamide. Invest Ophthalmol. 1965;4(5):927–934.
   PubMedGoogle Scholar
• Oppelt WW. Measurement of aqueous humor formation rates by posterior-anterior chamber perfusion with inulin: normal values and the effect of carbonic anhydrase inhibition. Invest Ophthalmol. 1967;6(1):76–83.
   PubMedGoogle Scholar
• Stamper RL, Lieberman MF, Drake MV Carbonic anhydrase inhibitors.: 13.
   Google Scholar
• Krupin T, Sly WS, Whyte MP, et al. Failure of acetazolamide to decrease intraocular pressure in patients with carbonic anhydrase II deficiency. Am J Ophthalmol. 1985;99(4):396–399.
   PubMed Web of Science ®Google Scholar
• Wistrand P. Local action of the carbonic anhydrase inhibitor, acetazoleamide, on the intraocular pressure in cats. Acta Pharmacol Toxicol (Copenh). 1957;14(1):27–37.
   PubMedGoogle Scholar
• Becker B. The mechanism of the fall in intraocular pressure induced by the carbonic anhydrase inhibitor, diamox. Am J Ophthalmol. 1955;39(2 Pt 2):177–184.
   PubMed Web of Science ®Google Scholar
• Friedman Z, Krupin T, Becker B. Ocular and systemic effects of acetazolamide in nephrectomized rabbits. Invest Ophthalmol Vis Sci. 1982;23(2):209–213.
   PubMed Web of Science ®Google Scholar
• Maren TH, Haywood JR, Chapman SK, et al. The pharmacology of methazolamide in relation to the treatment of glaucoma. Invest Ophthalmol Vis Sci. 1977;16(8):730–742.
   PubMed Web of Science ®Google Scholar
• Stone RA, Zimmerman TJ, Shin DH, et al. Low-dose methazolamide and intraocular pressure. Am J Ophthalmol. 1977;83(5):674–679.
   PubMed Web of Science ®Google Scholar
• Lewis RA, Schoenwald RD, Barfknecht CF, et al. Aminozolamide gel. A trial of a topical carbonic anhydrase inhibitor in ocular hypertension. Arch Ophthalmol Chic Ill. 1986;104(6):842–844.
   PubMedGoogle Scholar
• Bron AM, Lippa EA, Hofmann HM, et al. MK-927: a topically effective carbonic anhydrase inhibitor in patients. Arch Ophthalmol Chic Ill 1960. 1989;107(8):1143–1146.
   PubMedGoogle Scholar
• Berson FG, Epstein DL, Grant WM, et al. Acetazolamide dosage forms in the treatment of glaucoma. Arch Ophthalmol Chic Ill. 1980;98(6):1051–1054.
   PubMedGoogle Scholar
• Acetazolamide: Drug information - UpToDate. Accessed 2021 Jan 8. https://www.uptodate.com/contents/acetazolamide-drug-information?search=acetazolamide&source=panel_search_result&selectedTitle=1~110&usage_type=panel&kp_tab=drug_general&display_rank=1
   Google Scholar
• Hayashi K, Yoshida M, Manabe S, et al. Prophylactic effect of oral acetazolamide against intraocular pressure elevation after cataract surgery in eyes with glaucoma. Ophthalmology. 2017;124(5):701–708.
   PubMed Web of Science ®Google Scholar
• Lichter PR, Newman LP, Wheeler NC, et al. Patient tolerance to carbonic anhydrase inhibitors. Am J Ophthalmol. 1978;85(4):495–502.
   PubMed Web of Science ®Google Scholar
• Kalina PH, Kalina AG. Bilateral transient myopia induced by oral acetazolamide in the early postoperative period after phacoemulsification. JCRS Online Case Rep. 2020;8(2):e00016.
   Google Scholar
• Hill AD. Myopic changes in a climber after taking acetazolamide and the use of corrective lenses to temporize symptoms: a case report from mount kilimanjaro. Wilderness Environ Med. 2016;27(3):397–400.
   PubMed Web of Science ®Google Scholar
• Szawarski P, Hall-Thompson B. Acetazolamide-induced myopia at altitude. Wilderness Environ Med. 2009;20(3):300–301..
   PubMed Web of Science ®Google Scholar
• Muirhead JF, Scheie HG. Transient myopia after acetazolamide. Arch Ophthalmol. 1960;63(2):315–318.
   PubMedGoogle Scholar
• Back M. Transient myopia after use of acetazoleamide (Diamox). Arch Ophthalmol. 1956;55(4):546–547.
   Google Scholar
• Binder SS. Acute transient myopia associated with use of acetazolamide (Diamox). J Am Med Assoc. 1957;165(2):154. .
   PubMed Web of Science ®Google Scholar
• Kronning E. Transient myopia following the use of acetazolamide. Acta Ophthalmol (Copenh). 2009;35(5):478–484.
   Google Scholar
• Mattsson R. Transient myopia following the use of sulphonamides. Acta Ophthalmol (Copenh). 2009;30(4):385–398.
   Google Scholar
• Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007;18(2):129–133. .
   PubMed Web of Science ®Google Scholar
• Grigera JD, Grigera ED. Ultrasound biomicroscopy in acetazolamide-induced myopic shift with appositional angle closure. Arq Bras Oftalmol. 2017;80(5):327–329.
   PubMed Web of Science ®Google Scholar
• Mancino R, Varesi C, Cerulli A, et al. Acute bilateral angle-closure glaucoma and choroidal effusion associated with acetazolamide administration after cataract surgery. J Cataract Refract Surg. 2011;37(2):415–417.
   PubMed Web of Science ®Google Scholar
• Malagola R, Arrico L, Giannotti R, et al. Acetazolamide-induced cilio-choroidal effusion after cataract surgery: unusual posterior involvement. Drug Des Devel Ther. 2013;7:33–36.
   PubMed Web of Science ®Google Scholar
• Galin MA, Baras I, Zweifach P. Diamox-induced myopia. Am J Ophthalmol. 1962;54:237–240.
   PubMed Web of Science ®Google Scholar
• Diamox Sequels (acetazolamide) [prescribing information]. July 2008. Accessed 2021 Jan 9. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205358Orig1s000lbl.pdf
   Google Scholar
• Kesler A, Kupferminc M. Idiopathic Intracranial Hypertension and Pregnancy. Clin Obstet Gynecol. 2013;56(2):389–396. .
   PubMed Web of Science ®Google Scholar
• Falardeau J, Lobb BM, Golden S, et al. The use of acetazolamide during pregnancy in intracranial hypertension patients. J Neuroophthalmol. 2013;33(1):9–12.
   PubMed Web of Science ®Google Scholar
• Söderman P, Hartvig P, Fagerlund C. Acetazolamide excretion into human breast milk. Br J Clin Pharmacol. 1984;17(5):599–600.
   PubMed Web of Science ®Google Scholar
• Strelow B, Fleischman D. Glaucoma in pregnancy: an update. Curr Opin Ophthalmol. 2020;31(2):114–122.
   PubMed Web of Science ®Google Scholar
• Patterson R, Bello AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther. 1999;21(12):2065–2079.
   PubMed Web of Science ®Google Scholar
• Ghimire S, Kyung E, Lee JH, et al. An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications. J Clin Pharm Ther. 2013;38(3):196–202.
   PubMed Web of Science ®Google Scholar
• Brackett CC, Singh H, Block JH. Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group. Pharmacotherapy. 2004;24(7):856–870.
   PubMed Web of Science ®Google Scholar
• Wulf NR, Matuszewski KA. Sulfonamide cross-reactivity: is there evidence to support broad cross-allergenicity? Am J Health Syst Pharm. 2013;70(17):1483–1494.
   PubMed Web of Science ®Google Scholar
• Johnson KK, Green DL, Rife JP, et al. Sulfonamide cross-reactivity: fact or fiction? Ann Pharmacother. 2005;39(2):290–301.
   PubMed Web of Science ®Google Scholar
• Tzanakis N, Metzidaki G, Thermos K, et al. Anaphylactic shock after a single oral intake of acetazolamide. Br J Ophthalmol. 1998;82(5):584.
   PubMed Web of Science ®Google Scholar
• Gallerani M, Manzoli N, Fellin R, et al. Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide. Am J Emerg Med. 2002;20(4):371–372.
   PubMed Web of Science ®Google Scholar
• Gerhards LJ, Van Arnhem AC, Holman ND, et al. [Fatal anaphylactic reaction after oral acetazolamide (diamox) for glaucoma]. Ned Tijdschr Geneeskd. 2000;144(25):1228–1230.
   PubMedGoogle Scholar
• Zimmermann S, Achenbach S, Wolf M, et al. Recurrent shock and pulmonary edema due to acetazolamide medication after cataract surgery. Heart Lung. 2014;43(2):124–126.
   PubMed Web of Science ®Google Scholar
• Her Y, Kil MS, Park JH, et al. Stevens-Johnson syndrome induced by acetazolamide: acetazolamide-induced Stevens-Johnson syndrome. J Dermatol. 2011;38(3):272–275.
   PubMed Web of Science ®Google Scholar
• Pokhrel PK, Loftus SA. Ocular emergencies. Am Fam Physician. 2007;76(6):829–836.
   PubMed Web of Science ®Google Scholar
• Zhang L, Weizer JS, Musch DC. Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty. Cochrane Database Syst Rev. 2017;2:CD010746.
   PubMedGoogle Scholar
• Roy LF, Dufresne LR, Legault L, et al. Acetazolamide in hemodialysis patients: a rational use after ocular surgery. Am J Kidney Dis Off J Natl Kidney Found. 1992;20(6):650–652.
   PubMed Web of Science ®Google Scholar
• Schwenk MH, St Peter WL, Meese MG, et al. Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis. Pharmacotherapy. 1995;15(4):522–527.
   PubMed Web of Science ®Google Scholar
• Schwenk MH, Blaustein DA, Wagner JD. The pharmacokinetics of acetazolamide during CAPD. Adv Perit Dial Conf Perit Dial. 1994;10:44–46.
   PubMedGoogle Scholar
• Yue CS, Huynh HH, Raymond C, et al. Population pharmacokinetic and pharmacodynamic modeling of acetazolamide in peritoneal dialysis patients and healthy volunteers. J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm. 2013;16(1):89–98.
   Google Scholar